ABSTRACT
INTRODUCTION
Chronic kidney disease is an increasing health problem throughout the world including Bangladesh. It is a longstanding, progressive deterioration of renal function (1) .
The kidney normally plays an important role in the metabolism, degradation and excretion of several thyroid hormones. All levels of the hypothalamic-pituitary-thyroid axis may be involved, including alterations in hormone production, distribution, and excretion. As a result, abnormalities in thyroid function tests are frequently encountered in uremia (2, 3) . End-stage renal disease (ESRD) alters the hypothalamic-pituitary-thyroid hormone axis in addition to the peripheral thyroid hormone metabolism.
Among thyroid hormones, triodothyronine (T3) is the most metabolically active thyroid hormone and can be reduced in ESRD patients even with a normal TSH level. In general, reduced T3 levels in ESRD patients are due to the decreased peripheral tissue conversion of T4 into T3, while thyroid gland production of T3 is normal and T3 clearance rates are normal or decreased, as in other non-thyroidal illnesses (4) . Most patients with end-stage renal disease have decreased plasma levels of free triiodothyronine (FT3), which reflect diminished conversion of thyroxine (T4) to T3 in the periphery (5). This abnormality is not associated with increased conversion of T4 to the metabolically inactive reverse T3 (rT3), since plasma rT3 levels are typically normal. This finding differentiates the uremic patient from patients with chronic illness in which the conversion of T4 to T3 is similarly reduced, but the generation of rT3 from T4 is enhanced. In addition to decreased production, low levels of total T3 also may reflect reduced protein binding (6) . The kidney normally contributes to the clearance of iodide from the body.
With advancing renal failure iodide excretion is diminished leading sequentially to an elevated plasma inorganic iodide concentration and an initial increment in thyroidal iodide uptake. The ensuing marked increase in the intrathyroidal iodide pool results in diminished uptake of radiolabeled iodide by the thyroid in uremic patients. Increases in total body inorganic iodide can potentially block thyroid hormone production (the Wolff Chaikoff effect) (7, 8) .
Chronic renal failure affects thyroid function in multiple ways, including low circulating thyroid hormone concentration, altered peripheral hormone metabolism, disturbed binding to carrier proteins, possible reduction in tissue thyroid hormone content, and increased iodine store in thyroid glands (9) . The objective of the present study was to see the relationship between chronic kidney disease and thyroid functional status and also to see the effect of CKD on thyroid hormonal status and to stratify the severity of renal disease by eGFR and to correlate stages of CKD with serum FT3, FT4 and TSH level.
MATERIALS AND METHODS
It was a cross sectional study which was carried out at 
RESULTS
A total of 100 patients of CKD of different age groups were enrolled for this study. Out of them 11% of the patients were between the age of 20-29 years, 20% between 30-39 years, 33% between 40-49 years and 36% between the ages of 50-60 years. Mean age of the patient was 44.42±12.42 years of age, 63% were male and 37% were female giving a male: female ratio of nearly 1.7: 1 (Table-1). shows that out of 100 CKD patients of different stages II (11%) were suffering from primary hypothyroidism, 5 (5%) were from subclinical hypothyroidism and 45 (45%) were from low T3 syndrome and rest 39 (39 %) patients were free from any thyroid abnormality. were suffering from hypothyroidism, 1 (7.7%) were subclinical hypothyroidism and 4 ( 30.8%) were low T3 syndrome. In stage -II, out of 6 patients only 3 (50%) had low T3 syndrome ( Table-III T3 syndrome would be increased according to the increase of CKD stage. There was an increasing trend form the population of low T3 according to the increase of CKD stage. This study showed that low T3 syndrome was highly prevalent in CKD and was a remarkable finding in early CKD. Furthermore, serum T3 levels were associated with severity of CKD in normal TSH level (13) .
In this study only FT3 and FT4 levels were measured but total T3 and T4 levels were not measured. In future total T3 and T4 level should be measured to assess the peripheral conversion of T4 to T3. This is a small scale study, however this study provides a guideline for the diagnosis and management of the patients of CKD associated with thyroidal illness.
CONCLUSION
This study showed that high prevalence (11%) of primary hypothyroidism, low T3 syndrome (45%) and subclinical hypothyroidism (5%) in CKD and was a remarkable finding in CKD. Furthermore, there is an increasing trend of low serum FT3 levels (low T3 syndrome), Subclinical hypothyroidism and primary hypothyroidism according to the severity of CKD. So thyroid functional status should be evaluated in each and every patient of CKD especially of stage-III, IV and V that can reduce the morbidity and mortality rate of CKD patients as well as reduce the social burden and health expenditure.
